§ 69.04.001 Statement of purpose
§ 69.04.002 Introductory
§ 69.04.003 “Federal act” defined
§ 69.04.004 “Intrastate commerce.”
§ 69.04.005 “Sale.”
§ 69.04.006 “Director.”
§ 69.04.007 “Person.”
§ 69.04.008 “Food.”
§ 69.04.009 “Drugs.”
§ 69.04.010 “Device.”
§ 69.04.011 “Cosmetic.”
§ 69.04.012 “Official compendium.”
§ 69.04.013 “Label.”
§ 69.04.014 “Immediate container.”
§ 69.04.015 “Labeling.”
§ 69.04.016 “Misleading labeling or advertisement,” how determined
§ 69.04.017 “Antiseptic” as germicide
§ 69.04.018 “New drug” defined
§ 69.04.019 “Advertisement.”
§ 69.04.020 “Contaminated with filth.”
§ 69.04.040 Prohibited acts
§ 69.04.050 Remedy by injunction
§ 69.04.060 Criminal penalty for violations
§ 69.04.070 Additional penalty
§ 69.04.080 Avoidance of penalty
§ 69.04.090 Liability of disseminator of advertisement
§ 69.04.100 Condemnation of adulterated or misbranded article
§ 69.04.110 Embargo of articles
§ 69.04.120 Procedure on embargo
§ 69.04.130 Petitions may be consolidated
§ 69.04.140 Claimant entitled to sample
§ 69.04.150 Damages not recoverable if probable cause existed
§ 69.04.160 Prosecutions
§ 69.04.170 Minor infractions
§ 69.04.180 Proceedings to be in name of state
§ 69.04.370 Right of access for inspection
§ 69.04.410 Drugs — Adulteration by harmful substances
§ 69.04.420 Drugs — Adulteration for failure to comply with compendium standard
§ 69.04.430 Drugs — Adulteration for lack of represented purity or quality
§ 69.04.440 Drugs — Adulteration by admixture or substitution of ingredients
§ 69.04.450 Drugs — Misbranding by false labeling
§ 69.04.460 Packaged drugs — Misbranding
§ 69.04.470 Drugs — Misbranding by lack of prominent label
§ 69.04.480 Drugs — Misbranding for failure to state content of habit forming drug
§ 69.04.490 Drugs — Misbranding by failure to show usual name and ingredients
§ 69.04.500 Drugs — Misbranding by failure to give directions for use and warnings
§ 69.04.510 Drugs — Misbranding for improper packaging and labeling
§ 69.04.520 Drugs — Misbranding for failure to show possibility of deterioration
§ 69.04.530 Drugs — Misbranding by misleading representation
§ 69.04.540 Drugs — Misbranding by sale without prescription of drug requiring it
§ 69.04.550 Drugs exempt if in transit for completion purposes
§ 69.04.560 Dispensing of certain drugs exempt
§ 69.04.565 DMSO (dimethyl sulfoxide) authorized
§ 69.04.570 Introduction of new drug
§ 69.04.580 Application for introduction
§ 69.04.590 Effective date of application
§ 69.04.600 Denial of application
§ 69.04.610 Revocation of denial
§ 69.04.620 Service of order of denial
§ 69.04.630 Drug for investigational use exempt
§ 69.04.640 Court review of denial
§ 69.04.650 Dispensing of certain drugs exempt
§ 69.04.660 Federally licensed drugs exempt
§ 69.04.670 Cosmetics — Adulteration by injurious substances
§ 69.04.680 Cosmetics — Misbranding by false label, etc
§ 69.04.690 Cosmetics — Misbranding by lack of prominent label
§ 69.04.700 Cosmetics exempt if in transit for completion purposes
§ 69.04.710 Advertisement, when deemed false
§ 69.04.720 Advertising of cure of certain diseases deemed false
§ 69.04.730 Enforcement, where vested — Regulations
§ 69.04.740 Regulations to conform with federal regulations
§ 69.04.750 Hearings
§ 69.04.761 Hearing on proposed regulation — Procedure
§ 69.04.770 Review on petition prior to effective date
§ 69.04.780 Investigations — Samples — Right of entry — Verified statements
§ 69.04.790 Owner may obtain part of sample
§ 69.04.800 Access to records of other agencies
§ 69.04.810 Access to records of intrastate carriers
§ 69.04.820 Right of entry to factories, warehouses, vehicles, etc
§ 69.04.830 Publication of reports of judgments, orders and decrees
§ 69.04.840 Dissemination of information
§ 69.04.850 Construction — 1945 c 257
§ 69.04.860 Effective date of chapter — 1945 c 257
§ 69.04.880 Civil penalty

Terms Used In Washington Code > Chapter 69.04 - Intrastate commerce in drugs and cosmetics

  • Conviction: A judgement of guilt against a criminal defendant.
  • Corporation: A legal entity owned by the holders of shares of stock that have been issued, and that can own, receive, and transfer property, and carry on business in its own name.
  • Damages: Money paid by defendants to successful plaintiffs in civil cases to compensate the plaintiffs for their injuries.
  • Equitable: Pertaining to civil suits in "equity" rather than in "law." In English legal history, the courts of "law" could order the payment of damages and could afford no other remedy. See damages. A separate court of "equity" could order someone to do something or to cease to do something. See, e.g., injunction. In American jurisprudence, the federal courts have both legal and equitable power, but the distinction is still an important one. For example, a trial by jury is normally available in "law" cases but not in "equity" cases. Source: U.S. Courts
  • Evidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other.
  • Fraud: Intentional deception resulting in injury to another.
  • Injunction: An order of the court prohibiting (or compelling) the performance of a specific act to prevent irreparable damage or injury.
  • Jurisdiction: (1) The legal authority of a court to hear and decide a case. Concurrent jurisdiction exists when two courts have simultaneous responsibility for the same case. (2) The geographic area over which the court has authority to decide cases.
  • Partnership: A voluntary contract between two or more persons to pool some or all of their assets into a business, with the agreement that there will be a proportional sharing of profits and losses.
  • person: may be construed to include the United States, this state, or any state or territory, or any public or private corporation or limited liability company, as well as an individual. See Washington Code 1.16.080
  • Probable cause: A reasonable ground for belief that the offender violated a specific law.
  • Veto: The procedure established under the Constitution by which the President/Governor refuses to approve a bill or joint resolution and thus prevents its enactment into law. A regular veto occurs when the President/Governor returns the legislation to the house in which it originated. The President/Governor usually returns a vetoed bill with a message indicating his reasons for rejecting the measure. In Congress, the veto can be overridden only by a two-thirds vote in both the Senate and the House.